Immunogenicity of a Single Dose of GSK Biologicals' Diphtheria, Tetanus and Acellular Pertussis (dTpa) Booster Vaccine (Boostrix ) in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2018
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 04 Jun 2018 Status changed from not yet recruiting to recruiting.
- 17 May 2018 Planned End Date changed from 19 Feb 2019 to 15 Mar 2019.
- 17 May 2018 Planned primary completion date changed from 19 Feb 2019 to 15 Mar 2019.